Antiepileptic drug therapy: does mechanism of action matter?
about
Development of lacosamide for the treatment of partial-onset seizuresThe adolescent or adult with generalized tonic-clonic seizures.Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.Current position of phenobarbital in epilepsy and its future.Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data.Road to refractory epilepsy: the Glasgow story.The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.Allosteric modulation of sigma-1 receptors elicits anti-seizure activitiesSynthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2H-thiopyran-4-yl based thiazoles and selenazoles.Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective.Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.Novel anticonvulsants for reducing alcohol consumption: A review of evidence from preclinical rodent drinking models.Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.Eslicarbazepine acetate for partial-onset seizures.Lacosamide for the treatment of partial-onset seizures.Epileptic encephalopathies (including severe epilepsy syndromes).The long-term safety of antiepileptic drugs.Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.Sodium Channel Blockers in the Treatment of Epilepsy.Modern management of juvenile myoclonic epilepsy.Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.Glyoxalase 1 and its substrate methylglyoxal are novel regulators of seizure susceptibility.Seeking the Rational (or at least avoiding the irrational).A probabilistic method for determining cortical dynamics during seizures.New hope for the treatment of epilepsy.Differential effects of sodium channel blockers on in vitro induced epileptiform activities.A Caenorhabditis elegans assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action
P2860
Q24629140-3D389831-6F21-46B1-8F39-18967AAC7BFCQ33161273-86778700-18E5-4E4C-A258-B7B4E109E1CEQ33621804-D0402950-80F5-46EC-A8A3-AF69D677DB02Q34315078-9AA7815B-BAA5-4CBD-B253-64F00E1526D0Q34333196-12CEDE42-F6C3-475B-A7C6-31A74ADB746DQ34343111-3689C9F2-B9CA-4833-8A88-D83AA58AB534Q35537344-D55B6347-FC50-4807-8210-105E6398FAEDQ35978091-397223E0-3FB1-42D9-9B82-8D6D26010F88Q36021675-47211C65-EFB8-4ADD-90AB-F603B22F8A24Q36097620-753C4357-14EF-4312-848F-82B8E0F999B8Q36568597-BC57DA23-0F81-4E60-8472-F592078009E7Q37473125-C0DDB184-3B2B-4357-BCDF-72F0BAF05F03Q37696491-59722FA8-2F67-4D1E-B034-0FE10FAC1D62Q37957121-433DADFB-36A9-4582-AA56-2489930904DBQ38014885-36A4A879-61B5-40D5-9904-795566C9BABEQ38040452-A8DD6FE8-10FA-4054-AF03-640661DA1FE9Q38106856-6AEB2A71-BFC7-4261-B485-308B7EF0E000Q38199973-AA2BC267-BBC4-4608-9605-F76E8B9C7A63Q38617833-9BBFF883-51D3-41D9-AE4A-364789177427Q38775516-B3F822BB-753A-401E-94ED-A76C466C4907Q38809047-B58CC15A-7B7C-40B2-B655-38FA5DDC5200Q38904679-F721AEFC-2F6B-48D2-A9C6-4FDA2D62BCD0Q39647889-AABA029A-FC43-4A0A-B8A8-8E35FFCEFD58Q41454103-8E0DD64B-3CBA-49EA-A097-83A2372BC59DQ46601860-FBD1E6EF-1B78-4C2F-8460-F0FBD2966CF6Q47573219-C4D82246-5E8F-4B45-9346-A3C3401772AAQ52147387-F8C3DE95-C575-492E-9DD5-2B54C3B4833EQ58702262-40FECF9E-F07D-4716-9FFA-C74874AE49BB
P2860
Antiepileptic drug therapy: does mechanism of action matter?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiepileptic drug therapy: does mechanism of action matter?
@en
Antiepileptic drug therapy: does mechanism of action matter?
@nl
type
label
Antiepileptic drug therapy: does mechanism of action matter?
@en
Antiepileptic drug therapy: does mechanism of action matter?
@nl
prefLabel
Antiepileptic drug therapy: does mechanism of action matter?
@en
Antiepileptic drug therapy: does mechanism of action matter?
@nl
P2093
P50
P1433
P1476
Antiepileptic drug therapy: does mechanism of action matter?
@en
P2093
Antonio Gil-Nagel
Athanasios Covanis
H Steve White
Holger Lerche
P304
P356
10.1016/J.YEBEH.2011.05.025
P577
2011-07-16T00:00:00Z